Global Smart Biopsy Devices Market 2022-2028
Description
Global Smart Biopsy Devices Market 2022-2028
A biopsy is a diagnostic procedure where a tissue or cell sample is removed and then examined under a microscope. Biopsies are commonly used to determine whether a tumor or growth is cancerous or non-cancerous (benign). Smart biopsies allow real-time cancer tissue characterization and have been developed and are already being used in some hospitals to accelerate cancer diagnosis. According to Gen Consulting Company, the global smart biopsy devices market is projected to reach USD 3,552 million, recording a CAGR of approximately 4.3 percent from 2022 to 2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart biopsy devices market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the smart biopsy devices industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, and region. The global market for smart biopsy devices can be segmented by application: breast cancer, prostate cancer, skin cancer, liver cancer, others. Smart biopsy devices market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.
By application:
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
A biopsy is a diagnostic procedure where a tissue or cell sample is removed and then examined under a microscope. Biopsies are commonly used to determine whether a tumor or growth is cancerous or non-cancerous (benign). Smart biopsies allow real-time cancer tissue characterization and have been developed and are already being used in some hospitals to accelerate cancer diagnosis. According to Gen Consulting Company, the global smart biopsy devices market is projected to reach USD 3,552 million, recording a CAGR of approximately 4.3 percent from 2022 to 2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart biopsy devices market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the smart biopsy devices industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, and region. The global market for smart biopsy devices can be segmented by application: breast cancer, prostate cancer, skin cancer, liver cancer, others. Smart biopsy devices market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.
By application:
- breast cancer
- prostate cancer
- skin cancer
- liver cancer
- others
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global smart biopsy devices market.
- To classify and forecast the global smart biopsy devices market based on application, region.
- To identify drivers and challenges for the global smart biopsy devices market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global smart biopsy devices market.
- To identify and analyze the profile of leading players operating in the global smart biopsy devices market.
- Gain a reliable outlook of the global smart biopsy devices market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Table of Contents
65 Pages
- PART 1. INTRODUCTION
- Report description
- Objectives of the study
- Market segment
- Years considered for the report
- Currency
- Key target audience
- PART 2. METHODOLOGY
- PART 3. EXECUTIVE SUMMARY
- PART 4. MARKET OVERVIEW
- Introduction
- Drivers
- Restraints
- Impact of COVID-19 pandemic
- PART 5. MARKET BREAKDOWN BY APPLICATION
- Breast cancer
- Prostate cancer
- Skin cancer
- Liver cancer
- Others
- PART 6. MARKET BREAKDOWN BY REGION
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
- PART 7. KEY COMPANIES
- Argon Medical Devices, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corp.
- Canon Medical Systems Corporation
- Hologic Inc.
- innoMedicus Ltd.
- Planmed Oy
- *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
- DISCLAIMER
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
